E D IT I O NPHARMA CONSULTINGPeter O'Callaghan,Head of Expression System Sciences,LonzaSTRATEGIES TO OPTIMISE EXPRESSION CHALLENGES OF MULTI-CHAIN AND BISPECIFIC ANTIBODIESAUGUST - 21 - 2023APAC SPECIAL$15WWW.PHARMATECHOUTLOOK.COMISSN 2644-2787
Page 2 >